BDBM249184 US9457039, 7
SMILES: C[C@@]1(N)[C@H](O)[C@@H](CO)O[C@H]1c1cnn2c(N)ncnc12
InChI Key: InChIKey=BUPKMPMCEKZOJC-HGIWHZBTSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RNA-directed RNA polymerase (NS5B) (Hepatitis C virus genotype 1b (isolate BK) (HCV)) | BDBM249184 (US9457039, 7) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | 48 |
Merck Sharp & Dohme Corp. US Patent | Assay Description To measure cell-based anti-HCV activity of selected compounds of the present invention, replicon cells were seeded at 5000 cells/well in 96-well coll... | US Patent US9457039 (2016) BindingDB Entry DOI: 10.7270/Q2VD6XCW | |||||||||||
More data for this Ligand-Target Pair |